Elequin Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,700
Closed -$158K 582
2022
Q4
$158K Buy
15,700
+14,700
+1,470% +$146K 0.04% 212
2022
Q3
$10K Buy
+1,000
New +$9.82K ﹤0.01% 251

Other funds holding AONC

Elequin Capital's AONC Position: Q1 2023 in Review

Elequin Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 15,700 shares — an estimated $158K sold.

Elequin Capital first reported a position in AONC in Q3 2022 and held it in 2 quarters. The position peaked at $158K in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Elequin Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Elequin Capital sold 15,700 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $158K.
  • Elequin Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2022 and held it in 2 quarters.
  • Elequin Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $158K in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.